South African Medical News

Back to Home Page

Print using browser
Zyban sustained release tablets, bupropion (Aspen)


Dear Healthcare Professional

Aspen regrets to advise that ZYBAN sustained release tablets has been discontinued from the market with immediate effect.

This is due to supply issues.

If you have any further queries, please contact your Aspen representative, or the Aspen Customer Careline 0800 122 912.
  • This is a drug - read the leaflet carefully before use 
  • Ask your doctor or pharmacist for further information.
Aspen sincerely apologise for the inconvenience caused and assure you of their commitment to service excellence at all times

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

S5 ZYBAN. Reg. No.: 34/34/0374. Each tablet contains 150 mg of bupropion hydrochloride.

Marketed by Aspen Pharmacare. Building 12, Healthcare Park, Woodlands Drive, Woodmead, 2191.

You need to be logged in to see more details. Register Now!

Click here to visit the Aspen website....
Contact: Katlego Riet, Junior Brand Manager
Telephone: +27 (0) 11 239 3063
Date: Monday, October 7, 2019